Skip to main content
メニュー
JP

Resource Center

Filters
Select resource types
Select products & services
Select solutions (3)
Active Filters (3)
Clear All
1 - 12 of 215 Results
Sort by: Best Match
Best Match
Title A-Z
Title Z-A
Filter & Sort
Application Note Icon   Application Note
Developing novel tetraubiquitin substrates and AlphaLISA technology to provide next generation deubiquitinase assays
This application note presents novel biochemical DUB assays that use TUBEs to bind to tetraubiquitin substrates of at least three natural linkages. These assays, combined with Revvity’s AlphaLISA™ technology, allow for the measurement of protein interactions and large protein complexes in a no-wash, homogeneous assay.
Application Note Icon   Application Note
Detection of human matrix metalloproteinase 9 in complex sample matrices, a comparison of AlphaLISA and colorimetric ELISA immunoassays
This note compares two immunoassay technologies: ELISA (enzyme-linked immunosorbent assay) and AlphaLISA™ (amplified luminescent proximity-based homogeneous assay).
Flyer Icon   Flyer
Cellometer Spectrum image cytometer flyer
Flyer summarizing the Cellometer Spectrum image cytometer.
Whitepaper Icon   Whitepaper
Leveraging next-generation cell line development technologies for cost-effective biotherapeutic applications
Reviewing the transformative innovations within the cell line development process to help improve biotherapeutics.
Technical Note Icon   Technical Note
A scalable and reproducible workflow for high-content analysis of cytotoxic effects in RASTRUM 3D cell cultures
Explore our Technical Note on a scalable workflow for high-content cytotoxicity analysis in 3D cell cultures. Discover reproducible 3D model creation, tailored microenvironment techniques, and enhanced imaging methods for accurate drug testing.
Whitepaper Icon   Whitepaper
An emerging therapeutic modality - RNA carves its path out of the paradigm
Learn more about several promising classes of RNA therapeutic, including RNAi, CRISPR, base editing, and mRNA vaccines, as well as the potential to combine RNA technologies with CAR-T.
Whitepaper Icon   Whitepaper
Gene editing of primary immune cells to aid next-generation cellular immunotherapies
Researchers have successfully deployed CRISPRa/i in primary human T cells, offering critical insights into the pathways required for cytokine regulation.
Infographic Icon   Infographic
Functional genomic screening in drug discovery
In this infographic we present two screening approaches, pooled and array, summarize advantages, read-out methods and available products and technologies.
Application Note Icon   Application Note
Orthogonal validation of CRISPRCas9 and siRNA generated phenotypes using cell painting
Investigate cell cycle regulation through AURKB, GMNN, and PLK1 proteins. Learn how CRISPR-Cas9 and siRNA techniques, combined with high-content imaging on the Opera Phenix™ Plus, reveal their roles in cell division and genomic stability.
Whitepaper Icon   Whitepaper
How CRISPR-based functional genomics is transforming drug discovery
Exploring how functional genomics is used in preclinical drug discovery with target identification, drug response mechanisms, and in vivo tumor biology.
Poster Icon   Scientific Poster
CHOSOURCE ADCC+ cell line for enhanced therapeutic potency
Discover how the CHOSOURCE ADCC+ cell line increases Antibody Dependent Cellular Cytotoxicity (ADCC) for use in the production of biotherapeutics for oncology, anti-infectives and auto-immune diseases.
Poster Icon   Scientific Poster
Application of gene editing technologies to improve biotherapeutic manufacturing
Showcasing a multiplex gene editing approach with well-defined workflows and established tools to isolate, identify, and characterize edited knock-out or knock-in clones in different cell types.
resource-center-page-end-card-bg-illuminator.png
resource-center-page-end-card-bg-illuminator-mobile.png

Looking for technical documents?

Find the technical documents you need, ASAP, in our easy-to-search library.